Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 26;21(1):101.
doi: 10.1186/s12887-021-02556-9.

Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature

Affiliations
Review

Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature

Nasir Ud Din et al. BMC Pediatr. .

Abstract

Background: Gliosarcoma is a rare variant of IDH- wild type glioblastoma with both glial and mesenchymal differentiation. It accounts for approximately 2% of glioblastomas and has a poor prognosis similar to that of classic glioblastoma. It is seen mostly between 40 and 60 years of age with a mean age over 50 years. Pediatric gliosarcoma is even rarer than gliosarcoma in adults. We describe the clinicopathological features of gliosarcoma in patients under 20 years of age and determine whether there are significant differences from gliosarcoma in adults. We also present detailed review of published literature on pediatric gliosarcoma.

Methods: Slides of gliosarcomas in patients under 20 years of age were reviewed. Clinicopathological features were noted in detail and follow up was obtained.

Results: Eleven cases of gliosarcoma were reported in patients under 20 years of age. Ages ranged from three to 19 years (mean age 13 years). Frontal, parietal and temporal lobes were the commonest locations. Mean and median tumor size was six and five cm respectively. All 11 cases demonstrated the classic biphasic pattern. In 10 cases, glial component was astrocytic and was highlighted on GFAP. Sarcomatous component in most cases resembled fibrosarcoma and was high grade in 72.7%. Glial areas were reticulin poor while sarcomatous areas were reticulin rich. In over 45% cases, bizarre tumor giant cells were seen in the sarcomatous areas. In 1 case, sarcomatous areas showed extensive bone and cartilage formation. Other histologic features included hyalinized blood vessels, hemorrhage, infarction, gemistocytic cells, rhabdoid cells etc. Follow up was available in nine patients, five received chemoradiation post resection while three received radiotherapy only. Prognosis was dismal and eight patients died within one to 14 months following resection.

Conclusions: Gliosarcomas in patients under 20 comprised 13% of all gliosarcomas reported during the study period. Frequency and mean age were higher compared to other published reports. Pathological features were similar to those described in literature. Clinicopathological features and prognosis of pediatric gliosarcomas were similar to adult gliosarcomas.

Keywords: Astrocytic; Biphasic; Cerebral hemispheres; Glial; Glioblastoma; Gliosarcoma; Mesenchymal; Pediatric.

PubMed Disclaimer

Conflict of interest statement

It is declared that all authors have no conflict of interest.

Figures

Fig. 1
Fig. 1
a T2WI Axial Image: A well-defined rounded T2WI heterogenous signal intensity mass seen in right parietal lobe with significant perilesional edema. b T2WI Sagittal Image: A well-defined rounded T2WI heterogenous signal intensity mass seen in right parietal lobe with significant perilesional edema c T1 Axial post-contrast: Avid post contrast enhancing mass with few central hypointensities identified in right posterior parietal lobe and surrounding perilesional edema. d T1 coronal post contrast image: Avid post contrast enhancing mass with few central hypointensities identified in right posterior parietal lobe and shows surrounding perilesional edema
Fig. 2
Fig. 2
a Classic biphasic appearance of gliosarcoma. The mesenchymal elements at top are sharply demarcated from glial component at bottom. b Oligodendroglioma as glial component was seen in one case. c. GFAP expression in the glial component. d. Mesenchymal component appeared as fibrosarcoma in most cases
Fig. 3
Fig. 3
a. Vimentin positivity in mesenchymal component. b While glial areas are reticulin poor, c, mesenchymal component was reticulin rich. d. Focal bizarre tumor cells in mesenchymal component
Fig. 4
Fig. 4
a. Trabeculae of lamellar bone in mesenchymal component. b. Prominent large vessels were noted in some cases. c & d Sheets of gemistocytes and rhabdoid cells are focally seen in few cases

Similar articles

Cited by

References

    1. Burger PC, Giangaspero F, Ohgaki H, Bieruat W, et al. Gliosarcoma. In: Louis DN, Ohgaki H, WK WODC, Ellison DW, Figarella–Branger D, Perry A, et al., editors. WHO Classification of Tumours of the Central Nervous System. Revised 4th Edition. International Agency for Research on Cancer (IARC) Lyon. 2016. pp. 48–49.
    1. Galanis E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, et al. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: north central Cancer treatment group results. J Neurosurg. 1998;89:425–430. doi: 10.3171/jns.1998.89.3.0425. - DOI - PubMed
    1. Goldstein SJ, Young B, Markesberry WR. Congenital malignant gliosarcoma. AJNR Am J Neuroradiol. 1981;2:475–476. - PMC - PubMed
    1. McKeever PE, Wichman A, Chronwall B, Thomas C, Howard R. Sarcoma arising from a gliosarcoma. South Med J. 1984;77:1027–1032. doi: 10.1097/00007611-198408000-00023. - DOI - PubMed
    1. Cerame MA, Guthikonda M, Kohli CM. Extraneural metastases in gliosarcoma: a case report and review of the literature. Neurosurgery. 1985;17:413–418. doi: 10.1227/00006123-198509000-00003. - DOI - PubMed